Outcomes in patients with multiple myeloma with TP53 deletion after autologous hematopoietic stem cell transplant

av Gaballa, Sameh, Saliba, Rima M., Srour, Samer, Lu, Gary, Brammer, Jonathan E, Shah, Nina, Bashir, Qaiser, Patel, Krina, Bock, Fabian, Parmar, Simrit, Hosing, Chitra, Popat, Uday, Delgado, Ruby, Rondon, Gabriela, Shah, Jatin J., Manasanch, Elisabet E., Orlowski, Robert Z., Champlin, Richard, Qazilbash, Muzaffar
I publikationen Am J Hematol (2016)

Impact of TKIs post–allogeneic hematopoietic cell transplantation in Philadelphia chromosome–positive ALL

av Saini, Neeraj, Marin, David, Ledesma, Celina, Delgado, Ruby, Rondon, Gabriela, Popat, Uday R., Bashir, Qaiser, Hosing, Chitra M., Nieto, Yago, Alousi, Amin M., Qazilbash, Muzaffar H., Ciurea, Stefan, Shpall, Elizabeth, Khouri, Issa, Kantarjian, Hagop, Jabbour, Elias, Ravandi, Farhad, Champlin, Richard E., Kebriaei, Partow
I publikationen Blood (2020)

Phase 2 Clinical Trial of High-Dose Gemcitabine/Busulfan/Melphalan for Autologous Stem-Cell Transplantation in Relapsed/Refractory Myeloma: Matched-Pair Comparison with Melphalan

av Nieto, Yago, Valdez, Benigno C, Pingali, Sai R, Bassett, Roland, Delgado, Ruby, Nguyen, John, Shah, Nina, Popat, Uday, Jones, Roy B, Andersson, Borje S, Gulbis, Alison, Ahmed, Sairah, Bashir, Qaiser, Parmar, Simrit, Patel, Krina, Myers, Alan, Rondon, Gabriela, Orlowski, Robert Z, Champlin, Richard, Qazilbash, Muzaffar
I publikationen Lancet Haematol (2017)

Outcome of Autologous Hematopoietic Stem Cell Transplantation in Refractory Multiple Myeloma

av Veltri, Lauren W., Milton, Denái R., Delgado, Ruby, Shah, Nina, Patel, Krina, Nieto, Yago, Kebriaei, Partow, Popat, Uday R., Parmar, Simrit, Oran, Betul, Ciurea, Stefan, Hosing, Chitra, Lee, Hans C., Manasanch, Elisabet, Orlowski, Robert Z., Shpall, Elizabeth J., Champlin, Richard E., Qazilbash, Muzaffar H., Bashir, Qaiser
I publikationen Cancer (2017)

Outcome of patients with multiple myeloma and CKS1B gene amplification after autologous hematopoietic stem cell transplantation

av Bock, Fabian, Lu, Gary, Srour, Samer, Gaballa, Sameh, Lin, Heather Y., Baladandayuthapani, Veerabhadran, Honhar, Medhavi, Stich, Maximilian, Shah, Nina Das, Bashir, Qaiser, Patel, Krina, Popat, Uday, Hosing, Chitra, Korbling, Martin, Delgado, Ruby, Rondon, Gabriela, Shah, Jatin J, Thomas, Sheeba K, Manasanch, Elisabet E, Isermann, Berend, Orlowski, Robert Z, Champlin, Richard E, Qazilbash, Muzaffar H
I publikationen Biol Blood Marrow Transplant (2016)

Busulfan and melphalan conditioning is superior to melphalan alone in autologous stem cell transplantation for high-risk MM

av Saini, Neeraj, Bashir, Qaiser, Milton, Denái R., Tang, Guilin, Delgado, Ruby, Rondon, Gabriela, Popat, Uday R., Hosing, Chitra M., Nieto, Yago, Kebriaei, Partow, Alousi, Amin M., Mehta, Rohtesh, Srour, Samer, Khouri, Issa F., Weber, Donna M., Thomas, Sheeba K., Lee, Hans C., Patel, Krina K., Orlowski, Robert Z., Champlin, Richard E., Qazilbash, Muzaffar H.
I publikationen Blood Adv (2020)